Title: A Master Protocol to Evaluate Biomarker-Driven Therapies and Immunotherapies in Previously-Treated Non-Small Cell Lung Cancer (Lung-MAP Screening Study)
- Principal Investigator: Dr. Theodore Thomas
- Study Coordinator: April Phipps, Marlowe Mosley, Jason Atkinson, and Carla Prost
The primary objective of this screening study is to test patient specimens to determine eligibility for participation in the biomarker-driven and non-matched sub-studies included within the Lung-MAP umbrella protocol.
This study is administered by VREF and funded by the National Cancer Institute (NCI).
Find Out More
This study is currently enrolling. To learn more about LUNG MAP and how you can join contact our research office at (314) 289-7690.
If you are a veteran receiving care through the VA St. Louis Health Care System and believe you may be eligible for this study, please speak with your Physician. For general information about our research, please visit our main Clinical Trials page or contact us directly.